Revagenix
San Mateo
About Revagenix
Revagenix is a biopharmaceutical company discovering and developing therapies to address medical needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $4.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jan 2024)
- Website: revagenix.com
- Phone: (650) 228-3244
Industries & Categories
Biotechnology, Pharmaceutical, Service Industry
Social Profiles
Canonical: https://fsome.com/organization/revagenix-132240 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.